While some studies have shown that targeting of platelet membrane receptors, such as glycoprotein (GP)IIb-IIIa, by monoclonal antibodies or elimination of circulating platelets results in a significant reduction in the number of metastases in transplantable murine tumor models [11, 17], others report that inhibition of platelet receptors does not confer protection against tumor cell dissemination or rather increases metastasis formation. The gene discussed is ITGA2B; the disease is neoplasm.